Skip to content

Study of Heat Shock Proteins as Prognostic Factor of Acute Renal Failure in Children (HSP-Study)

Study of Heat Shock Proteins as Prognostic Factor of Acute Renal Failure in Children (HSP-Study)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00230412
Acronym
HSP
Enrollment
120
Registered
2005-09-30
Start date
2005-10-31
Completion date
2010-12-31
Last updated
2010-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Failure, Acute

Keywords

Kidney Failure, Acute, Acute Renal Failure, Kidney Failure, Heat-Shock Proteins, Children

Brief summary

The purpose of the investigators' study is to determine whether the production of heat shock proteins has an effect on the development and the outcome of acute renal failure in children.

Detailed description

A prognostic factor for the development of acute renal failure (ANR) in children would be very valuable for therapy regulation. So-called chaperones out of the family of heat shock proteins (HSP) are promising candidates which are involved in the development of ANR as well. This could be a starting point for the development of new therapeutic approaches. ANR occurs in up to 50 percent of all critical ill patients and has a high rate of morbidity and mortality despite advances in symptomatic therapy. Following severe sepsis, septic shock or other shocks, combined with multiple organ failure, the ANR is an autonomous prognosis worsening factor. Should the results of our study show a correlation between the production of HSP and the outcome of children with ANR, further studies would be required, to examine the pathophysiological relevance of HSP in ANR. We would then be able to determine a high risk population for ANR. A modulation of ANR therapy might be a result of further studies.

Interventions

None listed

Sponsors

Ludwig-Maximilians - University of Munich
CollaboratorOTHER
University of Munich Children's Clinic
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Between 0 and 18 years of age. * Either severe sepsis, shock of any origin or asphyxia. * Operated patients with operative or post-operative transfusion requirement of at least 0.5 x 80 ml/kg body weight of erythrocyte concentrate.

Exclusion criteria

* Existing affection of the kidney. * Kidney transplantation. * Missing written consent of the parents or guardian (if applicable).

Design outcomes

Primary

MeasureTime frame
Acute renal failure.28 days

Countries

Germany

Contacts

Primary ContactDennis A. Ballwieser, cand. med.
dennis.ballwieser@med.uni-muenchen.de+49-89-2621-7564
Backup ContactJudith Glöckner-Pagel, Dr. med.
judith.gloeckner@med.uni-muenchen.de+49-89-5160-2811

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026